Equity Method Accounted Investees - Share of OCI (Details) $ in Millions, $ in Millions |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
|
Dec. 31, 2025
USD ($)
|
[1] |
Dec. 31, 2025
MXN ($)
|
Dec. 31, 2024
MXN ($)
|
Dec. 31, 2023
MXN ($)
|
|||
| Items that may be reclassified to consolidated net income: | |||||||
| Total | $ (3) | $ (55) | $ 260 | $ 6,097 | |||
| Items that may not be reclassified to consolidated net income in subsequent periods: | |||||||
| Remeasurements of the net defined benefit liability | $ (81) | (1,457) | (1,016) | 160 | |||
| Equity investments | |||||||
| Items that may be reclassified to consolidated net income: | |||||||
| Valuation of the effective portion of derivative financial instruments | 0 | (32) | (526) | ||||
| Exchange differences on translating foreign operations | (55) | 292 | 6,623 | ||||
| Total | (55) | 260 | 6,097 | ||||
| Items that may not be reclassified to consolidated net income in subsequent periods: | |||||||
| Remeasurements of the net defined benefit liability | $ 0 | $ 0 | $ 897 | ||||
| |||||||